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Stimulation of lymphoid cells is now a  well established effect of such mitogens as 
endotoxic lipopolysaccharides [LPS, cf.  (1)], I concanavalin A  [Con A,  (2,  3)],  phyto- 
hemagglutin  [PHA,  (4)],  and  pokeweed mitogen  [PWM,  (4-6)].  Through  their ac- 
tions on lymphoid cells these substances have been most useful for elucidating cer- 
tain aspects of the mechanism of immunological reactivity. For instance, certain of 
the  endotoxins  have  been  characterized  as  improving humoral  antibody  synthesis 
towards other antigens both in vivo (7-9) and in vitro (10,  11).  More recently LPS 
have been shown to heighten the functions of bone marrow  (B) but not thymic (T) 
cells (12).  Indeed, the T  cell requirement in the IgM anti-SRBC hemolytic response 
of the mouse has been revealed to be replaceable by LPS (12,  13). 
Conversely, the stimulatory activities of Con A and of PHA are restricted primarily 
to T  cells (2-4,  14,  15) although Con A can be made to activate B  cells for immuno- 
globulin synthesis by making Con A insoluble (4). 
PWM on the other hand, may exert its activity upon both B  and T  cells (5). Its 
selective stimulation of IgM synthesis by mouse B lymphocytes has been dissociated 
from any antigenic property of the mitogen and has been characterized as an "aspe- 
cific" phenomenon (6). 
Purified protein derivative of tuberculin (PPD)  has been thought to cause blasto- 
genesis of essentially thymus-derived cells when  these originate from PPD-sensitive 
individuals (16-18). In the nonimmune condition, however, PPD  has been described 
as an effective B cell mitogen as well as a stimulator of B  cells for antibody synthesis 
to other nonrelated antigens (19,  20). 
We have recently shown  that dextran,  a  substance normally not considered 
to be a  mitogen,  alters immunological responses to heterologous antigenic and 
haptenic stimuli (21). In guinea pigs, low molecular weight dextran postponed 
delayed  dermal  hypersensitivity until  a  later  time  when skin responses  were 
greatly  exacerbated.  In  addition,  pretreatment  with  this  polysaccharide de- 
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pressed  the synthesis of circulating antibody that mediates passive cutaneous 
anaphylaxis  (PCA).  On  the  other  hand,  if  infused into  guinea pigs  with  es- 
tablished immunological responses dextran did not alter either delayed hyper- 
sensitivity or PCA antibody synthesis  (21). 
In  view  of  dextran's  clinical importance  as  a  blood  plasma  expander  and 
as an ingredient of certain medications, we thought it appropriate to ascertain 
the  breadth  of  applicability of its  effects.  In  particular,  we  wished  to  know 
whether  it  disrupted  the  normal  course  of  immunological responses  such  as 
IgM and IgG synthesis. Further, we wished to determine if any immunological 
alterations were  detectable  at  a  cellular level where  the  possibility exists for 
elucidating certain  events  associated  with  the  mechanisms of  immunological 
responsiveness and unresponsiveness. 
Materials and Methods 
Dextran Treatment of Guinea Pigs.--Guinea  pigs,  of both Hartley (The Rockefeller  Uni- 
versity, New York) and Pirbright (Animal Virus Research Institute, Pirbright Woking, Sur- 
rey, England) strains, were intrajugularly injected with 300 mg of dextran (Pharmacia Fine 
Chemicals, Inc., Piscataway, N. J., clinical grade H  lot no. H1763, average molecular weight 
186,000) 6 or 24 h  before  introducing antigen.  The  latter was  a  0.25%  sheep  red  blood 
cell (SRBC)  suspension in  1 cc  volume given intraperitoneally. Control animals received 
SRBC only. 
Plaquing.--At  4.5  days after injecting SRBC,  animals were sacrificed,  their spleens re- 
moved, and cells separated by passage through nylon mesh. It is noteworthy to mention that 
most all of the determinations of plaque-forming cells (PFC) on spleens of guinea pigs were 
done at 4.5 days, a  time that is near maximal for IgM and IgG PFC in this animal (22). 
Cells were counted, washed,  reconstituted to suspensions of 105 and 106 per cubic centimeter 
using Earle's balanced  salt  solution  (Grand Island Biological  Co.,  Grand Island, N. Y.). 
The Jerne method (23) of plaquing was used to determine IgM and the Wortis modification 
(24) was used for identifying IgG. Rabbit antibody to guinea pig "g-globulin (1:50) was used 
to detect IgG synthesis and pooled guinea pig sera  (1:15) was the source  of complement. 
Total time of incubation was 3 h at 37°C in a 5% COs atmosphere. 
Treatment of Controls.--To test for cross-reactivity of dextran to SRBC, guinea pigs were 
inoculated intravenously with 300 mg of dextran and their spleen cells plaqued against SRBC 
at 4.5 days. 
To determine whether a  booster effect was being achieved by administering dextran be- 
fore SRBC, some animals were given two injections of SRBC 6 h apart and their spleen cells 
were plaqued at 4.5 days. 
To determine if endotoxin would mimic the dextran effect,  100 #g  of Escherichla toll 
lipopolysaccharide (055 :B5 Difco Laboratories, Detroit, Mich.) in 2 ml volume was injected 
intravenously  at either 6 or 24 h before SRBC, and spleen cells of these animals were plaqued 
at the usual 4.5 days. 
Spleen cells from untreated animals were used to measure background counts. 
Dextran Treatment of Miee.--Mice  used were CBA/Wh and CBA/J. Injections of dextran 
(amounts stipulated in tables were  contained in 0.3  cc volume) were via the retro-orbital 
sinus at indicated intervals before antigen (SRBC). Plaquing routinely occurred at 4.5 days 
after intraperitoneally administered antigen. For developing indirect PFC rabbit antimouse 
IgG (Cappel Laboratories, Downingtown, Pa.) was used. 
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untreated mice. B cells (107) alone or B  (10 v) and T  (20  X  106) together were then injected 
intravenously into X-rayed (900 R)  syngeneic recipients. Representatives from both groups 
were treated with dextran (12 nag) 24 h before SRBC. The remainder were given only SRBC. 
Plaquing as before was done at 4.5 days. 
The effect of dextran on T  cells alone was done in two ways. In the first method, T  cells 
(80  X  106) from donor animals were transferred to X-rayed recipients. 12 rag  dextran was 
injected intravenously into each animal and 24 h later spleens removed, cells separated, mixed 
with untreated B cells (107 B and 20  X  l0 G  T), and injected into X-rayed recipients. SRBC 
were given intraperitoneally 24 h later and plaquing was done at 4.5 days. 
The second method used was an in vitro treatment of T  cells with dextran. A mixture 
containing T  cells,  5% mouse serum,  1% antibiotic (penicillin-streptomycin, Grand Island 
Biological  Co.), and dextran (0.1-1  rag/1 cc) was incubated for 2 h  at 37~C. Cells were then 
spun,  supernatant removed, and  cells  brought to  a  concentration of  20  X  106  in  0.1  cc, 
mixed with normal B cells (107 per 0.1 cc) and injected into X-rayed recipients. Total amount 
of cells given one animal was 40  X  l0 G  T  and 20  X  106 B. SRBC were given 24 h  later and 
spleen cells plaqued at 4.5 days. 
Culturing  Cells In Vitro.--For guinea pigs the preparation, culture, and harvest of lympho- 
cytic cultures were done as has been described (25). 
For mice, essentially the same procedures were maintained except that the culture medium 
was RPMI-1640 (Grand Island Biological  Co.)  to which was added  antibiotics, glutamine, 
and fetal  calf serum. 
The dextran added was the same as that used for the other experiments and the concen- 
trations were those indicated in Table IV. 
RESULTS 
The guinea pig is a particularly good animal species in which to observe the 
alterations  of  immunological  reactions  that  are  inducible  by  dextran.  Typi- 
cally,  one  dose  of  dextran  intravenously  administered  before  an  intraperi- 
toneal injection of SRBC caused a profound increase in the synthesis of IgM to 
SRBC.  Whereas  guinea  pigs  given  SRBC  alone  possessed  10  direct plaque- 
forming cells (DPFC) per million spleen cells, animals pretreated with dextran 
6 h before SRBC had 20 times this number (Table I). Allowing 24 h to elapse 
between  the injections  of dextran  and  SRBC  caused  a  sevenfold  increase  in 
DPFC per million. The total number of DPFC in the spleens of these animals 
also reflected the dextran  effect since a 46-fold improvement  occurred at the 
6 h pretreatment  and a sevenfold improvement was apparent  at the 24 h in- 
terval  (Table I). Thus, IgM  synthesis in guinea pigs would appear  to be op- 
timally altered by the shorter rather than the longer interval allowed between 
administering dextran and antigen. 
Synthesis  of IgG in guinea pigs was also markedly  increased by  the poly- 
saccharide, but in a different time sequence. For this particular immunoglobu- 
lin,  the  longer  24  h  interval  between  dextran  and  antigen  administration 
favored  production  of  IgG.  Thus,  whereas  a  threefold  increase  in  indirect 
plaque-forming  cells  (IPFC)  per  million  spleen  cells  assayed  was  noted  at 
the 6 h interval (Table II), a 39-fold increase was apparent at the 24 h period. 
In parallel, the total number of IPFC per spleen was greater at 24 h (28 times 
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TABLE I 
Dextran-Induced  Alterations  in IgM Synthesis by Guinea Pigs to SRBC 
Pretreatment  Antigen  No. of guinea  DPFC* 
pigs  Per 10  6  Per spleen 
None  SRBC  5  10  5,204 
Dex:~ 2 h before  SRBC  2  5  1,714 
Dex 6 h before  SRBC  2  204  238,666 
Dex 24 h before  SRBC  2  70  34,822 
Dex 48 h before  SRBC  2  54  29,119 
* Detected 4.5 days after injection of SRBC. 
:~ 300 mg dextran per kilogram body weight. 
TABLE II 
Increased  IgG Synthesis  to  SRBC in  Guinea  Pigs Attributable  to  Dextran 
Pretreatment  Antigen  No. of guinea  IPFC* 
pigs  Per 10  6  Per spleen 
None  SRBC  5  3  1,995 
Dex~ 2 h before  SRBC  2  2  1,336 
Dex 6 h before  SRBC  2  9  11,439 
Dex 24 h before  SRBC  2  117  55,880 
Dex 48 h before  SRBC  2  0  0 
* Detected 4.5 days after injection of SRBC. 
:~ 300 mg dextran per kilogram body weight. 
antigen,  IgG  antibody  synthesis  ceased  whereas  IgM  antibody  production 
continued.  Thus,  simply  by  pretreating  with  dextran,  an  unusually  greater 
synthesis of IgG to SRBC can be made to occur in guinea pigs at a  time that 
is ordinarily not optimal for this species. 
Certain  controls  essential for  establishing  the  manner  in  which  dextran 
exerts its influence upon immunological responses are presented in Table III. 
To  ascertain  the  background  count  of  cells  producing  antibody  to  SRBC, 
spleen cells from unimmunized guinea pigs were examined. Approximately the 
same number  of DPFC  was observed in animals immunized intraperitoneally 
with  one  dose of SRBC  at 4.5  days as was  seen in  control animals given no 
SRBC. A small number of IPFC were seen in immunized guinea pigs that were 
not detectable in unimmunized animals. 
Two sorts of tests were made to determine whether dextran possesses anti- 
genic cross-reactivity with SRBC. In the first, guinea pigs were injected with 
dextran  alone  and  their  spleen  cells  were  examined  4.5  days  later for  PFC 
toward SRBC. As shown in Table III, the number of DPFC  and IPFC paral- 
leled those of unimmunized animals. In the second test, five different concen- 
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TABLE  III 
Pertinent  Controls for Establishing the bJ~munological Changes Induced  by Dextran 
No. of  I)PFC*  IPFC* 
Pretreatment  Antigen  guinea 
pigs  Per 106  Per spleen  Per l0 s  Per spleen 
None  None  3  10  3,414  0  0 
None  SRBC  5  10  5,204  3  1,995 
Dex$  None  2  12  6,488  0  0 
SRBC 6 h before  SRBC  1  11  4,262  4  1,550 
Endotoxin§ 6 h before  SRBC  1  6  3,936  0  0 
Endotoxin,  24 h before  SRBC  1  14  8,352  0  0 
* To SRBC detected 4.5 days after injection of SRBC. 
:~ 300 mg dextran per kilogram body weight. 
§ From Escherichia  coli;  100 /~g per animal  (lethal dose for 50~%o of the animals approxi- 
mates 500 #g per kilogram). 
of antibody to SRBC (1:300 dilution of antiserum possessing endpoint hemag- 
glutination titer of 1:900) before the addition of appropriate amount of SRBC 
(0.25 %  suspension).  After suitable  incubation  no inhibition  of the  agglutina- 
tion was observed  (these  data  are not given in the  tables).  By these  two cri- 
teria  it  was  concluded  that  dextran  is  not  antigenically  cross-reactive  with 
SRBC. 
To find out if the dextran pretreatment of guinea pigs was acting in a manner 
akin to the first injection of antigen in a booster-type immunization,  a  guinea 
pig was injected twice with SRBC 6 h  apart. The number of DPFC and IPFC 
(Table III) was not appreciably different from those of animals injected  once 
with  SRBC, thus suggesting that dextran's influence is not that of a  booster- 
effect in the classical sense. 
Whether  an endotoxin-type of adjuvanticity  could explain  dextran's  activ- 
ity  on  immune  responses  was  examined  by pretreating  guinea  pigs  with  an 
endotoxin preparation from Escherichia coli. A dose of 100 ~g per animal given 
either 6 or 24 h  before SRBC was not able to alter the IgM or IgG responses 
in a  manner comparable to dextran  (Table III). 
To  determine  whether  dextran's  exacerbation  of immunoglobulin  synthesis 
is limited to one species of animal or alternatively is a widespread phenomenon, 
another  species  was  utilized.  That  the  finding  is  basic  to the  immunological 
response  mechanism  in  general  may be  seen  from the  data  gathered  as  well 
in  the  mouse  (Table  IV).  The  number  of DPFC  per  million  was not  signifi- 
cantly different from the control value when dextran preceded antigen by 2 h. 
Thereafter  the DPFC  increased until  a  maximum  number was attained  when 
the  interval  between  dextran  and  antigen  was  24  h. 
The IPFC response  was  the  mirror image of the  DPFC  response.  A  maxi- 
mal improvement in the number per million  (fourfold over the  control value) 
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of IgG-producing cells decreased as the interval between the two was lengthened 
(Table IV). 
With  slight  modifications  the  total  number  of  PFC  per  spleen  conveyed 
the same impressions (Table IV). Whereas the total number of IPFC paralleled 
the number per million rather well,  two changes were noted in DPFC:  a  two- 
fold increase was seen at 2 h and the maximum number appeared at 6 h rather 
than at 24. 
Of particular  importance  is  the  fact  that  in  mice  pretreated  48  h  before 
SRBC,  a  six- to  sevenfold decrease in IPFC  per million  and  per spleen  was 
observed (Table IV).  Thus,  depending  upon  when  the polysaccharide is  ad- 
ministered relative to antigen it can cause an increase as well as a decrease in 
the number of cells synthesizing IgM and IgG antibody. 
TABLE IV 
Heightened  IgM  and IgG Synthesis  as well as Depressed  IgG Prodnction to  SRBC  in  Mice 
Evoked by Polysaccharide  Pretreatment 
Treatment of mice  Direct PFC~  Indirect PFC~ 
No. of mice 
Dextran*  Antigen  Per 10P  Per spleen  Per 106  Per spleen 
None  SRBC  8  146  12,701  282  23,282 
2 h before  SRBC  4  124  24,304  1,000  196,000 
6 h before  SRBC  3  273  52,219  713  136,874 
24 h before  SRBC  6  310  33,016  311  34,983 
48 h before  SRBC  4  288  36,186  40  3,485 
* 12 mg of dextran intravenously. 
Detected 4.5 days after injection of SRBC. 
To  establish  the  optimally  effective  dose  of  dextran  necessary  to  induce 
heightened  immunological responses in  guinea  pigs  and  mice,  groups  of ani- 
mals were injected  with varying doses  of dextran  6  h  before SRBC.  Spleens 
were assayed for DPFC  and IPFC 4.5  days later. A  dose of 3 mg/10 g  body 
weight  was  maximally operative for increasing  DPFC  in  guinea  pigs  while 
1 rag/10 g body weight was effective for both DPFC and IPFC in the mouse. 
With  larger  doses  only a  slight  decline  in  stimulatory effectiveness occurred 
(Figs. 1 and 2). 
One  of the more direct  explanations for the mechanism by which  dextran 
exerts  its  effect upon  the  immunological  system is  to  assume  it  provides  a 
stimulus  for cells  to divide.  This possibility was examined both in  vivo and. 
in vitro. Two in vivo tests were made in mice and one in guinea pigs. In the 
first,  mice  were  given  dextran  intravenously  (5  mg/10  g)  and  their  spleen 
cells were counted  at various intervals  thereafter. A  twofold improvement in 
the total cell counts was observed at 4.5 days. In the second, mice were irradi- 
ated with 900 R  and then given fixed numbers of B  cells, T  cells,  or B  and T 
cells. Each group was then divided in half and one-half the animals were given 182  POLYSACCHARIDE  REGULATION  OF  IGG  AND  IG~¢[ SYNTHESIS 
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FIG. 2. Optimal dose of dextran that alters immune responses of CBA mice. 
the standard dose of dextran. Counts were made of the cells in spleens at 24 h 
and at 4.5 days. Again approximately a  twofold rise over background controls 
was apparent in each cell type as well as in the mixture at both time intervals. 
The in vivo test in guinea pigs was conducted just as was  the first in vivo 
test in mice except that the dose of dextran given was 3 rag/10 g body weight. 
Just  as with  the mice a  twofold increase in spleen cells was noted  at the 4th 
to 5th day. 
For in vitro tests, the lymph node cells of a  normal guinea pig and the bone 
marrow,  thymic as well as spleen cells of a  mouse were grown in the presence 
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thymidine 24 h before harvesting and the amount of label retained by the cells 
was ascertained by liquid  scintillation counting.  Over the entire 96 h  dextran 
provided  no  appreciable  stimulus  to  any of  the  cells  from  either  species  of 
animal  to  undergo  blastogenesis  that  differed  significantly from control  cul- 
tures (Table V). 
To ascertain  at  what level in  the immunological system dextran  exerts its 
effect, B  and  T  cells were  treated  separately both in vivo and in  vitro with 
dextran before immunization. In the first experiment CBA mice that had been 
irradiated  with 900 R  were given 20 X  106 B  cells.  A  number of the  cell re- 
cipients  were then  treated intravenously with dextran  (5  rag/10 g)  and  24 h 
TABLE  V 
Inability of Dextran to Induce Blastogenesis of Nonimmunized Lymphoid Cells Grown In Vitro 
Animal species  Cells  (no.)~  10-~)  Dextran 
CPM  * 
48 h  72 h  96 h 
Guinea pig 
Mouse 
~g 
Lymph node  None  1,172  804  752 
(10)  10  821  775  660 
100  833  554  589 
500  911  702  939 
Bone marrow  None  5,822  4,950  ND:~ 
(2)  10  5,990  4,783 
100  6,242  5,175 
Thymus  None  1,122  1,040  ND 
(2)  10  1,705  903 
100  1,431  1,138 
Spleen  None  4,715  12,658  ND 
(2)  I0  4,077  14,374 
100  3,892  11,214 
* Mean counts per minute of duplicate or triplicate cultures. 
:~ ND, not determined. 
later  both  treated  and  untreated  animals  were  immunized  with  SRBC.  As 
expected, mice receiving B  cells and SRBC only showed the background num- 
ber of DPFC (12 per million) and no IPFC (Table VI). 
In  contrast,  B  cell  recipients  that  had  been  pretreated  with  dextran  24 
h  before  SRBC  showed  the  full  number  of DPFC  (31  per  million)  that  is 
normally seen when B  and T  cells are given together. In concert with the un- 
treated  mice,  no  IPFC  were  observed in  dextran-treated  B  cell  recipients. 
Ordinarily, no IPFC are seen in B and T cell recipients at 4.5 days of immuniza- 
tion with SRBC. 
Two experiments were conducted  to determine whether dextran affects the 
activity of T  cells.  In one,  T  cells were simply incubated  for 2 h  in vitro in 
Earle's balanced salt solution containing dextran (1 mg/ml). The T  cells were 
thereafter washed in excess Earle's BSS and, in combination with normal un- 184  POLYSACCHARIDE  REGULATION-  OF  IGG  AND  IGM  SYNTHESIS 
TABLE VI 
IgM Synthesis  at 4.5 days: Substitution  of T Cells' Effect upon B Cells by Dextran. 
IgG Synthesis  at  4.5  days:  Requirement  for  T  Cells' Effect  upon  Dextran-Primed  B  Cells 
Cells  transferred 
No.  of  No.  per million  (:t:SD) 
Treatment of cell recipients  recipients  DPFC  IPFC 
B only  No dextran;  SRBC  6  12  (5)  0 
B only  Dextran 6 or 24 h pre-  8  31  (10)  0 
SRBC 
B -I- T  No dextran;  SRBC  2  39  (20)  0 
T  (dextran-treated)  -I-  No dextran; SRBC  6  43  (17)  0 
normal B 
B -[- T  Dextran 6 or 24 h pre-  6  52  (30)  58  (58) 
SRBC 
B (dextran-treated)  +  No dextran;  SRBC  5  38  (33)  33  (33) 
normal T 
treated  B  cells,  injected  into  X-irradiated  recipients  that  were  then  immu- 
nized with  SRBC. These animals demonstrated  the number of DPFC  (36 per 
million)  that normally is  seen  when  these  two  types of cells  cooperate.  They 
also did not demonstrate IPFC which again is a normal event at this immuniza- 
tion period. These data are not given in the table. 
In the second experiment T  cells were treated  in vivo with  dextran.  In this 
case  80 X  106  T  cells  from  normal  CBA  mice  were  given  each  X-rayed  re- 
cipient  and half of these  animals  were treated  intravenously  with  12  mg dex- 
tran. 24 h  later the animals of both sets were sacrificed, their spleens removed, 
and  cells  expressed.  The  T  cells  from  spleens,  after  washing  and  counting, 
were mixed with normal B  cells (10 X  106 B  +  20 X  106 T) for injection into 
new  X-rayed  animals  that  were  subsequently  immunized  with  SRBC.  The 
number of DPFC for both groups of mice was the same as seen previously (43 
per million) and there were no IPFC (Table VI). These  two experiments suggest 
but do not prove that dextran may have no direct effect upon T  cells. 
To further determine the level of dextran's activity, B  and T  cells from nor- 
real  donors  were  given  to  X~rayed  recipients  (20 X  106  and  40 X  106, re- 
spectively)  and  the latter  were treated  with dextran  24 h  before injecting the 
antigen,  SRBC.  Not  only  was  the  normal  number  of  DPFC  attained  (52 
per million)  but,  in addition,  IPFC became evident for the first time  (58 per 
million).  Thus,  the  T  cell  is  a  necessary  requirement  for  causing  dextran- 
primed B  cells to synthesize IgG earlier  in the immunization  schedule. 
Nevertheless,  it remained  unclear  whether  T  cells nmst also be  affected by 
dextran  to  allow IgG synthesis  to proceed  at  this  early  stage.  A  further  ex- 
periment  involving treatment  of B  cells  alone with dextran  and  mixing  these 
with  normal  T  cells  was  required  to  clarify  this  point.  B  cells  (50  X  106) 
were given each of several X-irradiated mice and the next day they were given JACK  R.  BATTISTO  AND  FRANCES  PAPPAS  185 
dextran (5 mg/10 g) intravenously. 2 h later they were sacrificed, their spleens 
removed, and cells expressed. These B cells, after washing  and  counting,  were 
mixed with normal T  cells (20)<  10  G  B +  40 X  106 T) for injection into new 
X-rayed animals that were subsequently immunized with SRBC. The number 
of DPFC and IPFC approximated those seen when B  and T  cells were given 
animals that had received dextran 6 or 24 h before SRBC. This experiment also 
suggests yet does not prove that dextran acts primarily upon B  cells and  not 
upon T  cells.  A rigorous proof necessitates removal of the small number of T 
cells known to be present among bone marrow cells. 
DISCUSSION 
Administering dextran to guinea pigs  and mice caused marked  alterations 
in  their abilities to synthesize IgM  and IgG to heterologous antigen,  SRBC 
(Tables I, II, and IV). The minimal dose that produced a maximal stimulating 
effect on  antibody synthesis was  3  rag/10 g  of body weight for guinea pigs 
(Fig. 1) and 1 rag/10 g of body weight for mice (Fig. 2). However, once achieved 
the maximum effect was observed over a rather wide dose range in each species. 
To determine whether improvement in antibody synthesis was attributable 
to antigens  held in  common by dextran  and  SRBC,  three  tests  were made. 
Dextran, when given alone as antigen to guinea pigs, was unable to stimulate 
an  increased  number  of SRBC-specific PFC  of either the  direct  or  indirect 
variety (Table III). In the second test, incubating dextran in several concen- 
trations with SRBC-specific antibody did not inhibit agglutination of SRBC. 
Furthermore,  administering  SRBC  instead  of dextran  before the  regular in- 
jection of SRBC did not mimic dextran's mobilization of IgM and IgG pro- 
duction (Table III).  Finally, we have reported elsewhere that dextran alters 
immunological  responses  of  guinea  pigs  to  stimuli  other  than  SRBC,  i.e., 
bovine gamma globulin and picryl chloride (21). Thus, the described dextran 
activation is not attributable to cross-reactive antigenic prestimulation of anti- 
body-producing cells. 
Whether the effect could be assigned to an endotoxic quality of the dextran 
preparation  appeared,  at  the  outset,  unlikely.  This  was  inferred  since  anti- 
body stimulation  by dextran was  achieved by giving dextran before antigen 
whereas endotoxin has been reported to be effective when given after antigen 
(10). Nevertheless,  to investigate the possibility, endotoxin from Escherichia 
coli  was given to guinea pigs before SRBC. When the numbers of DPFC and 
IPFC from these animals were seen to be similar to those of nontreated con- 
trol animals, this possibility was dismissed (Table III). 
One mechanism by which dextran stimulates  the immunological apparatus 
could conceivably be by causing lymphoid cells  to divide. This idea was  ex- 
amined exhaustively in the two animal species both in vivo and in vitro. Dex- 
tran given in vivo was able to cause the number of viable lymphoid cells pres- 
ent  in  the  spleens  of both  sorts  of animals  to  increase  twofold.  This  result 186  POLYSACCHARIDE  REGULATION OF  I(~G  AND  IGM  SYNTHESIS 
was observable 4  to 5  days after giving dextran.  In  addition,  both B  and  T 
cells  separately  transferred  to X-irradiated  mice,  showed  a  twofold  increase 
in number in those mice given dextran. 
Actually, a  twofold division of spleen cells appears unlikely to account for 
the large increase in SRBC-specific PFC. Only if the replication were a  selec- 
tive  one  among  certain  clones  of  ceils  might  many more divisions  have  oc- 
curred  while  maintaining  an  overall  appearance  of  a  twofold  increase.  Yet 
in vitro the lymph node cells of guinea pigs and the bone marrow, thymic, and 
spleen cells of mice revealed no dextran-induced blastogenesis as measured by 
thymidine uptake (Table V). Thus, if the in vivo replication is to be considered 
significant,  dextran  administration  must be assumed to have elicited  the  ap- 
pearance of an intermediary product in vivo capable of inducing blastogenesis. 
However, since B  cells exposed in vitro to dextran were able, upon transfer to 
X-rayed mice, to show a  heightened  immune response to SRBC  (Table VI), 
it  is unlikely  that dextran  acts primarily in  a  mitogenic manner.  In  this  re- 
spect it is unlike PPD, PWM, and LPS, all of which induce B  cell blastogene- 
sis (3, 5,  19). 
For  any explanation  of  the  mechanism  by which  dextran  alters  immuno- 
logical responses, knowledge of its effects at the cellular level becomes neces- 
sary. By treating B  and T  cells separately with dextran both in vivo and in 
vitro, and then transferring them to X-rayed animals that were subsequently 
immunized, it was found that B but not T  cells were primarily affected by dex- 
tran.  Actually,  exposing B  cells  to dextran  either  in  vitro or in vivo caused 
DPFC  to appear in numbers ordinarily seen only when normal B  and T  cells 
act in  concert.  Although  dextran's action  would  thus  appear to be primarily 
upon B  cells, it could conceivably be directed to the small number of T  cells 
known to be present in bone marrow preparations. Experiments to remove these 
T  cells  with  anti-0  antibodies  and  complement are in  progress.  If dextran's 
effect is solely upon  the  B  cell  then  it  is  able  to substitute  for one function 
performed by T  cells.  In this regard it would parallel the action of LPS, PWM, 
and PPD,  all of which stimulate B  cells to IgM synthesis in the absence of T 
cells (6,  12,  13, 20). On the other hand, if dextran acts upon the small number 
of T  cells residing in bone marrow it would be amplifying their effect upon B 
cells. 
As has been reported, B  cells alone do not cause the appearance of IPFC to 
SRBC in vivo (26). Our data (Table VI) support this observation and we fur- 
ther  show that B  cells primed with  dextran  still remain unable  to cause the 
appearance in vivo of IPFC. In our experience not even B and T  cells together 
will  cause IPFC  to SRBC  to appear at 4.5  days of immunization.  However, 
mice  given ]3  and  T  cells  and  subsequently  given dextran  in  vivo do  make 
IPFC at 4.5  days. Indeed, dextran-primed B  cells in conjunction with normal 
T  cells  will  also  make  the  same number  of IPFC  at  this  early  time.  Thus, 
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interaction with B  cells,  dextran in  conjunction with T  cells  causes greater 
numbers of B cells to synthesize IgG earlier than normal (Table VI). 
Since the synthesis of antibodies to many polysaccharides has been shown 
to be T  cell independent (27-30), the key to the mechanism by which dextran 
affects  immunological  responses  toward  T  cell-dependent  antigens  may lie 
in this direction. Thus, an interaction of B cells with a simple polysaccharide, 
such as dextran,  may cause changes  (permeability?) such that  the cells  be- 
come receptive to other haptenic or antigenic information. Informed B  cells 
then synthesize the only antibody of which they are capable in the absence of 
T  cells, i.e., IgM. It must be stressed that not all polysaccharides indiscrimi- 
nately possess  this capacity. Pneumococcal polysaccharide Type III injected 
into mice 3 days before SRBC has been reported not to influence the eventual 
response to the erythrocytes (31). 
In view of the fact that T cells secrete a nonspecific humoral factor that acts 
on  B  cells'  proliferation or  maturation  (32-34),  it  would  be  interesting  to 
speculate  whether  that  factor  is  a  polysaccharide-containing molecule.  An 
extrapolation  of  this  thought  would  be  to  consider  whether  PPD,  PWM, 
and  endotoxins derive  their  activity  upon  B  cells  from contained polysac- 
charides. 
Whether to classify dextran as an adjuvant is problematic. The properties 
that a  substance must possess to allow  its consideration as an adjuvant are 
not perfectly clear.  To  be  sure  dextran directly increases  the number  of B 
cells synthesizing IgM and, in conjunction with T  cells, improves the number 
of B cells making IgG, but it does so only when given at certain time intervals 
relative to antigen. For instance, in the guinea pig dextran given 6 h  before 
SRBC caused a marked stimulation of IgM-PFC but when given 24 h before 
erythrocytes it resulted in heightened IgG-PFC (Tables I, II). Such odd be- 
havior does not make it fit the normal pattern of an adjuvant. In addition, 
dextran  caused  a  definite  dislocation  of  delayed  hypersensitivity responses 
as well as a depression of PCA-antibody synthesis in guinea pigs (21).  These 
qualities would hardly characterize  it  as  an  adjuvant.  At  the  cellular level 
adjuvants have been shown to alter macrophages so as to markedly improve 
immune responses  (35).  It  has  been  suggested  that  adjuvant  increases  the 
effectiveness of the interaction of macrophages and T  lymphocytes and that 
this  results  in  greater  stimulation  of  B  ]ymphocytes to  produce  antibody 
(36).  This is particularly apparent for IgG and much less  a  requirement for 
IgM  synthesis  (37).  Thus,  the  stimulation  of  T  cells  and/or  macrophages 
appears to be an important aspect of the mechanism of action of at least some 
adjuvants. 
Dextran's  effect upon  macrophages  has not yet been  investigated in  this 
context. However, since dextran-primed B cells plus normal T  cells transferred 
to irradiated mice resulted in increased numbers of PFC  (Table VI), only B 188  POLYSACCHARIDE  REGULATION  OF  IGG  AND  IoM  SYNTHESIS 
cell-associated dextran  could have affected macrophages and T  cells.  Without 
doubt,  grouping  dextran  with adjuvants must await further developments. 
Since  dextran  alters  cell-mediated  and  humoral  antibody  responses,  its 
effects  have  significance  for  the  mechanisms involving  these  responses.  Two 
areas  beyond  those  already  discussed  are  particularly  pertinent  to  examine. 
One  involves  the  shifts  in  IgM  and  IgG  synthesis  while  the  other  concerns 
factors that activate and inhibit antibody production. 
Fig.  3 has been prepared to allow close comparisons of the manner in which 
dextran  influences  the  shifts  in  synthesis  of IgG  and  IgM  that  occur  in  the 
two  species  of  animals.  At  the outset  when no dextran  but  only  SRBC  was 
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FIo. 3. Influence of dextran on the shifts in synthesis of IgG and IgM. 
given  and spleen cells were examined 4.5  days later, the guinea pig had more 
DPFC  than  IPFC.  The  opposite  was  true in  the  CBA  mouse. 
When dextran was given 2 h before SRBC there was a small, almost imper- 
ceptible,  dip in the number of DPFC  in animals of both species. At this time 
whereas little change was seen in the IPFC of the guinea pig, those of the mouse 
increased  to  a  maximum.  An  obvious  question  to  be  answered  is  why  the 
shorter  2  h  exposure  to  dextran  should  improve  IgG  synthesis  to  SRBC  so 
dramatically in the mouse but not the guinea pig. The answer may be that the 
immunological response  to  SRBC  would  appear  to  be  a  primary  one  in  the 
guinea pig but a  secondary one in  the CBA mouse. In this connection, virgin 
precursor  cells  have  been  reported  to  have  IgM  receptors  on  their  surfaces 
regardless  of  the  class  of  antibody  they  eventually  secrete.  In  addition,  a 
temporary change in receptors from IgM  to IgG  occurred after a  single  anti- 
genic  exposure  but  prolonged  immunization induced  a  more permanent  shift 
(38). 
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in animals  of both species (Fig. 3). With  this pretreatment the IPFC of the 
guinea pig had begun to increase while those of the mouse decreased. Under 
the influence of dextran it is approximately at this point in time that synthe- 
sis of immunoglobulins shifts. The change is from M  to G  in  the guinea pig 
but from G to M  in the mouse. It is not suggested here that dextran initiates 
the shifts directly. Rather the shifts may be triggered by factors generated in 
vivo, perhaps  by T  cells.  This is  suggested  because IgG production in  par- 
ticular does not occur to SRBC in vivo in the absence of T cells (26 and Table 
VI). 
The close synchrony in  the  shifts of antibody synthesis in  animals  of the 
two species suggests that one B cell may be producing both immunoglobulins. 
This is inferred because a simultaneous increase in cells synthesizing both types 
of immunoglobulins has not been observed. Rather the production of one in- 
creases only when the other decreases. 
The maximum number of IPFC was not seen in the guinea pig until 24 h 
were allowed to elapse between dextran and SRBC. With a 48 h  interval be- 
tween  dextran  and  SRBC,  animals  of  both  species  had  approximately  the 
same number of DPFC  and both demonstrated a  dramatic cessation of IgG 
synthesis  (Fig.  3).  This  indicates  that  the  stimulating  factor  that  provided 
an increased synthesis of IgG at the early intervals was not only absent by 48 
h but that some inhibiting factor caused cessation of IgG production. At the 
same  time,  however,  IgM  production  remained  stimulated.  An  inhibitor  of 
IgG is inferred since in animals not treateJ with dextran, production of IgG is 
greater than in those that are pretreated with dextran at 48 h. These data sug- 
gest that the factor that stimulates IgM may act also to depress IgG and vice 
versa. Were this  so, only two factors would  be required to explain both in- 
creases and decreases in  synthesis of these two immunoglobulins. 
Thus  far,  one stimulator  and  one inhibitor have  been  described for IgM 
synthesis (39). Working with the mouse spleen cells' response to SRBC, Dutton 
has shown that Con A inhibits the in vitro response. He describes one short- 
lived T  cell  that produces an inhibitor effect upon B  cells and  a  separate T 
cell that produces a stimulating effect. Whether these same factors would affect 
IgG synthesis is as yet unknown. 
Resolution of the  problems of one vs.  two sets  of cells for IgM  and  IgG 
synthesis as well as how many factors are involved in initiation and cessation 
of immunoglobulin  synthesis must  await results  of further work which  may 
well be benefited by the use of dextran. 
In view of the fact that such drastic alterations in immunological responses 
can be induced by administering dextran, its clinical uses may well bear closer 
scrutiny. We are persuaded to this view by initial observations of mice given 
Maloney sarcoma virus  and  treated with  dextran.  Depending upon  when it 
was  given relative to  the virus, dextran caused  threefold increases in  tumor 
size over those of controls (Battisto and Pappas,  unpublished data). 190  POLYSACCHARIDE  REGULATION  OF  IGG  AND  I(~M  SYNTHESIS 
SUMMARY 
Dextran,  of the  variety commonly used  as plasma expander, markedly al- 
tered  antibody  synthesis  to  an  unrelated  antigenic  stimulus,  SRBC,  in  two 
animal  species,  guinea  pig  and  mouse.  The  time  at  which  dextran  was  ad- 
ministered relative to antigen  was found  to be most critical for increasing or 
decreasing  the  number of IgM and  IgG PFC.  Furthermore,  these  times dif- 
fered for the two species studied. 
Typically, when  given  to guinea pigs 6  h  before SRBC,  dextran  caused  a 
20-fold  rise in  IgM-producing  cells but  had  little  effect upon  IgG synthesis. 
However, if dextran preceded antigen by 24 h  the same magnitude of increase 
was seen in IgG-forming cells while a decrease in IgM-producing cells occurred. 
In  mice,  a  short  2  h  interval  between  dextran  and  antigen  favored  cells 
synthesizing IgG and not those producing IgM. A longer 6  to 24 h  lapse be- 
tween dextran  and  antigen  resulted  again in  an inverted pattern,  i.e.,  an in- 
crease in IgM and a decrease in IgG-producing cells. 
In both species, if dextran was given 48 h  before antigen,  synthesis of IgG 
markedly decreased. 
At the cellular level dextran activated those B  cells already in the vascular 
compartment.  In  stimulating  the  IgM  response  to  SRBC,  dextran  appears 
either to substitute for T  cells or to amplify the effects of that small number of 
T  cells  still  present  in  bone  marrow preparations.  Dextran-altered  mouse  B 
cells synthesized  SRBC-specific IgG in  the  presence of normal T  cells  at  an 
earlier time than did normal B  and T  cells.  However, dextran was unable  to 
cause blastogenesis in vitro of guinea pig lymph node cells or mouse B, T, and 
spleen cells. 
The data suggest at least two effects that T  cells exert upon B  cells. One is 
to stimulate more B  cells to produce IgM, a function  accomplished by endo- 
toxins,  PWM,  PPD,  and  the  simple polysaccharide dextran.  The other is to 
trigger shifts in synthesis of immunoglobulins M  and G. Our observations are 
compatible with the view that a  single cell is capable of synthesizing both of 
these  immunoglobulins  and  that  the  stimulating  factor  for  one  may  cause 
cessation of the other. 
Note Added in Pro@--After submission  of this  article we learned  of  the work by 
Diamantstein et al. 1971. Eur. J. Immunol.  1:302;  335; 340;  426; 429. They  docu- 
ment in mice the stimulation of hulnoral antibody formation by the poiyanions dex- 
tran sulfate,  polyacrylic acid, and polymannuronic-guluronic acid. Further, they sug- 
gest that polyanions substitute  for thymus cell  function  in  the  immunological  re- 
sponse of bone marrow cells to sheep erythrocytes. 
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